VEROSPIRON

Medicinal product

(Invented) name

VEROSPIRON

Active substance (s)

Spironolaktonas

Strength

50 mg

Pharmaceutical form

kietosios kapsulės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C03DA01, Spironolactone

Marketing authorisation holder

Gedeon Richter Plc, Vengrija

Date of authorisation

1999-07-02

Date of renewal

2008-02-22

Documents

1032 VEROSPIRON kaps PCS PL 2022 02 24.docx

1032 Pakuotės lapelis kaps 2022 02 24.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10a

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Kapsulėje yra	1 vnt.
Spironolaktonas	50 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
7346	3239	1003239	lizdinė plokštelė	N30		Receptinis	LT/1/94/1032/002	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2023-10-31	Išregistruotas
2008-02-22	Perregistruotas
1999-07-02	Registruotas